Creo Medical Group PLC (LON:CREO – Get Free Report)’s stock price reached a new 52-week low during trading on Monday . The company traded as low as GBX 24 ($0.32) and last traded at GBX 24 ($0.32), with a volume of 433847 shares. The stock had previously closed at GBX 26.68 ($0.36).
Creo Medical Group Trading Down 10.0 %
The firm has a market cap of £86.83 million, a PE ratio of -385.21 and a beta of 0.86. The firm has a 50 day moving average of GBX 29.30 and a 200 day moving average of GBX 33.03. The company has a quick ratio of 2.19, a current ratio of 3.83 and a debt-to-equity ratio of 13.88.
About Creo Medical Group
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
Read More
- Five stocks we like better than Creo Medical Group
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- Most Volatile Stocks, What Investors Need to Know
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Dividend Capture Strategy: What You Need to Know
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
